Commission Implementing Decision (EU) 2018/1251 of 18 September 2018 not approving empenthrin as an existing active substance for use in biocidal products of product-type 18
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
154/2019 In force in the EEA
Yes Legal documents
Commission Implementing Decision (EU) 2018/1251 of 18 September 2018 not approving empenthrin as an existing active substance for use in biocidal products of product-type 18
Framkvæmdarákvörðun framkvæmdastjórnarinnar (ESB) 2018/1251 frá 18. september 2018 um að samþykkja ekki empentrín sem fyrirliggjandi virkt efni til notkunar í sæfivörur í vöruflokki 18
Durchführungsbeschluss (EU) 2018/1251 der Kommission vom 18. September 2018 zur Nichtgenehmigung von Empenthrin als alten Wirkstoff zur Verwendung in Biozidprodukten der Produktart 18
Kommisjonens gjennomføringsbeslutning (EU) 2018/1251 av 18. september 2018 om ikke å godkjenne empentrin som eksisterende aktivt stoff til bruk i biocidprodukter av type 18
History
15.06.2019
Adopted JCD confirmed entry into force date
15.06.2019
Compliance date in the EEA
14.06.2019
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
02.05.2019
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
18.09.2018
Adoption date in the EU
09.10.2018
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.